Autologous humanized mouse models to study combination and single-agent immunotherapy for colorectal cancer patient-derived xenograftsPreeti Kanikarla Marie, Scott Kopetz|Frontiers in Oncology|2022Cited by 19
Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal CancerKristen K. Ciombor, H. Charles Manning, Seong-Woo Bae et al.|Clinical Cancer Research|2025Cited by 16
Supplementary Methods 1 from Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal CancerKristen K. Ciombor, H. Charles Manning, Seong-Woo Bae et al.|Unknown|2025Cited by 0
Table S3 from Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal CancerKristen K. Ciombor, H. Charles Manning, Seong-Woo Bae et al.|Unknown|2025Cited by 0
Figure S7 from Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal CancerKristen K. Ciombor, H. Charles Manning, Seong-Woo Bae et al.|Unknown|2025Cited by 0